12.5 Implantable Devices, Lines & Lead-Related Echocardiographic Findings

12.5 Implantable Devices, Lines & Lead-Related Echocardiographic Findings

Clinical Core: Content outline task 4.A.15 asks the candidate to identify implantable devices and lines, naming catheters and pacemaker and defibrillator leads specifically. Hardware inside the heart is now routine in pediatric cardiology, and almost every question a clinician asks about it is answerable by echocardiography: Where is the tip? Is there anything stuck to it? What valve is it disturbing? Is there an effusion? A sonographer who traces every line from its entry point to its tip, in more than one plane, answers all four.

---

Central Venous Catheters

Pediatric oncology, intensive care, and cardiac surgery all depend on long-term central access: peripherally inserted central catheters, tunneled Broviac or Hickman catheters, and implanted ports.

• Target tip position: the cavoatrial junction or the low superior vena cava. Tips advanced deep into the right atrium risk perforation and arrhythmia; tips left high in the innominate or subclavian vein risk thrombosis.
• Echocardiographic appearance: two closely spaced parallel hyperechoic lines — the anterior and posterior catheter walls — often described as a "double track" or "railroad" appearance. The lumen between them is anechoic.
• Best windows: subcostal bicaval and a modified apical four-chamber angled to open the right atrium and superior vena cava. A high right parasternal window helps in older children. Always confirm in two planes, because a catheter crossing the imaging plane obliquely produces a single dot that is easy to misinterpret.

Catheter-Related Complications

---

Umbilical Venous Catheters in the Neonate

The umbilical venous catheter follows an anatomically fixed path: umbilical vein → left portal vein → ductus venosus → inferior vena cava → right atrium.

• Correct tip: at the inferior vena cava to right atrial junction, just above the diaphragm.
• Malpositions to report: deep in the right atrium; across a patent foramen ovale into the left atrium; wedged in a hepatic vein branch (risk of hepatic necrosis and portal venous injury); or looped back into the portal system.
• Technique: a subcostal long-axis sweep following the intrahepatic course, supplemented by agitated saline through the catheter when the tip is ambiguous. Bedside echocardiography is more accurate than a plain radiograph for this determination and avoids repeated radiation in a preterm infant.

---

Extracorporeal Membrane Oxygenation Cannulae

• Venoarterial ECMO: a drainage cannula in the right atrium (via the internal jugular vein or directly at open sternotomy) and a return cannula in the aorta or common carotid artery. Echocardiography confirms cannula position, and then monitors for the problems that ECMO creates: left ventricular distension from inadequate unloading, failure of the aortic valve to open, and left atrial or left ventricular thrombus from stasis. Persistent aortic valve closure with a dilated left ventricle is the indication for a left ventricular vent or atrial septostomy.
• Venovenous ECMO: a dual-lumen cannula in the right internal jugular vein whose return port must be directed across the tricuspid valve to minimize recirculation; echocardiography confirms that the return jet is aimed correctly.
• Weaning assessments use serial ventricular function and the degree of aortic valve opening at reduced flows.

---

Pacing and Defibrillator Systems

Transvenous Versus Epicardial: A Pediatric Decision

The exam expects the reasoning behind the pediatric preference: a growing child's transvenous lead is eventually outgrown, and an intracardiac shunt turns a thrombogenic intravascular lead into a direct conduit to the systemic circulation.

What to Look For on the Echocardiogram

1. Trace each lead as a bright linear echodensity from the superior vena cava through the right atrium, across the tricuspid valve, to its myocardial fixation point. Count the leads and document which chambers they occupy.
2. Tricuspid valve function. Lead-related tricuspid regurgitation arises by three mechanisms:
   • Impingement — the lead mechanically props a leaflet open, usually the septal or posterior leaflet.
   • Adherence or entanglement — the lead becomes encased in fibrous tissue or tangled in the subvalvar apparatus, tethering a leaflet.
   • Perforation — the lead passes through the leaflet body, creating a fixed regurgitant orifice. Two-dimensional imaging often cannot resolve which leaflet is involved because the lead shadows the valve; three-dimensional en face imaging of the tricuspid valve from the right ventricular perspective resolves the lead–leaflet relationship and is the modality of choice for surgical planning.
3. Vegetation and thrombus. Cardiac implantable electronic device infection produces lead-adherent mobile echodensities; transesophageal echocardiography is far more sensitive than transthoracic imaging for lead vegetations and should be recommended when device infection is suspected.
4. Pericardial effusion. New effusion after implantation suggests lead perforation of a thin-walled chamber.
5. Superior vena cava and innominate vein patency. Loss of respiratory phasicity and continuous flow indicate stenosis, a common consequence of chronic transvenous leads in small veins.
6. Left ventricular function and synchrony. Chronic right ventricular apical pacing produces an electrically induced left bundle branch pattern with septal-to-posterior wall motion delay, reduced global longitudinal strain, and in a minority of children an overt pacing-induced cardiomyopathy. Ejection fraction and strain must be trended at every device follow-up; a falling value prompts consideration of an alternative pacing site (septal or His-bundle) or cardiac resynchronization therapy.

Other Implanted Hardware

• Leadless pacemakers appear as a compact echodense capsule fixed to the right ventricular apical or septal endocardium with no transvenous lead.
• Subcutaneous implantable cardioverter-defibrillators have no intracardiac hardware, which makes them attractive in patients with shunts or limited venous access; the echocardiogram shows no intracardiac lead.
• Ventricular assist devices are covered in the preceding section; the inflow cannula position at the left ventricular apex directed toward the mitral valve, aortic valve opening frequency, right ventricular function, and septal position are the recurring assessment points.
• Septal occluders, ductal devices, and vascular stents are covered in the following section.

---

The Universal Device Checklist

Regardless of the hardware, a complete report answers the same six questions:

1. What is it? Name the device and count the components.
2. Where does it go? Trace the full intracardiac course in at least two planes.
3. Where is the tip? State it against the intended target.
4. Is anything on it? Thrombus, vegetation, fibrin sheath.
5. What is it disturbing? Valve function, chamber size, venous patency, flow obstruction.
6. Is there an effusion? With tamponade assessment if present.

---

Exam-Day Traps

• Confusing a catheter with a linear artifact. A true catheter shows two parallel walls and is traceable across multiple frames and planes; a reverberation artifact is not.
• Reporting tricuspid regurgitation severity without naming the mechanism. Whether the lead impinges, adheres, or perforates determines whether the valve can be repaired at the time of lead revision.
• Relying on transthoracic imaging to exclude lead vegetation. The lead shadows the structures behind it; transesophageal echocardiography is required.
• Forgetting that a device patient still needs a functional study. The most clinically consequential finding in a chronically paced child is often a quietly falling ejection fraction, not the hardware itself.
• Ignoring the shunt question. In any patient with a transvenous lead, confirm whether an atrial communication exists, because it converts a lead thrombus into a stroke risk.